HOUSTON, Dec. 07, 2022 (GLOBE NEWSWIRE) -- In news that will completely change the way breast cancer is staged across the U.S. while reducing the reliance on uncertain radioactive tracer availability, ...
Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results